Skip to main content
Erschienen in: Pathology & Oncology Research 1/2010

01.03.2010

Prognostic Factors and Survival of Renal Clear Cell Carcinoma Patients with Bone Metastases

verfasst von: Attila Szendrői, Elek Dinya, Magdolna Kardos, A. Marcel Szász, Zsuzsanna Németh, Katalin Áts, János Kiss, Imre Antal, Imre Romics, Miklós Szendrői

Erschienen in: Pathology & Oncology Research | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

In our retrospective study the pathological and clinical factors, influencing the survival of 65 renal clear cell carcinoma patients operated for bone metastasis between 1990 and 2008 were examined. Based on Kaplan-Meier curves age, gender, clinical symptoms, pathological fracture, progression to the soft tissues, localization and size of the metastasis, whether the occurrence of multiplex metastases is multiorganic or only located to the skeletal system and the stage and grade of primary renal cancer did not influence the survival. The survival significantly improved if the bone metastases were solitary, low Fuhrman grade, late onset; and radical surgery was performed. Based on Cox regression analysis, survival after bone surgery was influenced by the multiplicity and grade of metastasis and by the radicality of the surgery, whereas survival after nephrectomy was significantly influenced by onset time and grade of metastasis. When the solitary metastasis was radically removed, 75.0% of the patients survived the first, and 35.5% the fifth postoperative year. If the metastasis was multiple or the surgery was not radical, no patient survived the fifth year. This is the first report on the prognostic significance of the Fuhrman grade of bone metastasis of renal cell cancer. While the Fuhrman grade of the primary tumour did not influence the survival, the lower grade of metastasis was associated with a significant longer survival. Therefore in cases of solitary, operable, late onset metastases with low Fuhrman grade radical removal is recommended, since this way in 35.5% of cases 5 year survival can be expected.
Literatur
1.
Zurück zum Zitat Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58(2):71–96CrossRefPubMed Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58(2):71–96CrossRefPubMed
2.
Zurück zum Zitat Kozlowski JM (1994) Management of distant solitary recurrence in the patient with renal cancer. Urol Clin North Am 21(4):601–624PubMed Kozlowski JM (1994) Management of distant solitary recurrence in the patient with renal cancer. Urol Clin North Am 21(4):601–624PubMed
3.
4.
Zurück zum Zitat Toyoda Y, Shinohara N, Harabayashi T et al (2007) Survival and prognostic classification of patients with metastatic renal cell carcinoma of bone. Eur Urol 52(1):163–169CrossRefPubMed Toyoda Y, Shinohara N, Harabayashi T et al (2007) Survival and prognostic classification of patients with metastatic renal cell carcinoma of bone. Eur Urol 52(1):163–169CrossRefPubMed
5.
Zurück zum Zitat Barney JD, Churchill EJ (1939) Adenocarcinoma of the kidney with metastasis to the lung: cured by nephrectomy and lobectomy. J Urol 42:269–276 Barney JD, Churchill EJ (1939) Adenocarcinoma of the kidney with metastasis to the lung: cured by nephrectomy and lobectomy. J Urol 42:269–276
6.
Zurück zum Zitat Fuchs B, Trousdale RT, Rock MG (2005) Solitary bony metastasis from renal cell carcinoma. Clin Orth Rel Res 431:187–192CrossRef Fuchs B, Trousdale RT, Rock MG (2005) Solitary bony metastasis from renal cell carcinoma. Clin Orth Rel Res 431:187–192CrossRef
7.
Zurück zum Zitat Szendrői M, Sárváry A (2001) Surgery of bone metastases. In: Besznyák I (ed) Diagnosis and surgery of organ metastases, 1st edn. Akadémiai Kiadó, Budapest Szendrői M, Sárváry A (2001) Surgery of bone metastases. In: Besznyák I (ed) Diagnosis and surgery of organ metastases, 1st edn. Akadémiai Kiadó, Budapest
8.
Zurück zum Zitat Han R, Pantuck AJ, Bui MHT et al (2003) Number of metastatic sites rather than location dictates overall survival of patients with node negative metastatic renal cell carcinoma. Urology 61:314–319CrossRefPubMed Han R, Pantuck AJ, Bui MHT et al (2003) Number of metastatic sites rather than location dictates overall survival of patients with node negative metastatic renal cell carcinoma. Urology 61:314–319CrossRefPubMed
9.
Zurück zum Zitat Lin PP, Mirza AN, Lewis VO et al (2007) Patient survival after surgery for osseous metastases from renal cell carcinoma. J Bone Joint Surg 89:1794–1801CrossRefPubMed Lin PP, Mirza AN, Lewis VO et al (2007) Patient survival after surgery for osseous metastases from renal cell carcinoma. J Bone Joint Surg 89:1794–1801CrossRefPubMed
10.
Zurück zum Zitat Althausen P, Althausen A, Jennings LC et al (1997) Prognostic factors and surgical treatment of osseous metastases secondary to renal cell carcinoma cancer. 80:1103–1109 Althausen P, Althausen A, Jennings LC et al (1997) Prognostic factors and surgical treatment of osseous metastases secondary to renal cell carcinoma cancer. 80:1103–1109
11.
Zurück zum Zitat Kollender Y, Bickels J, Price WM et al (2000) Metastatic renal cell carcinoma of bone: indications and technique of surgical intervention. J Urol 164:1505–1508CrossRefPubMed Kollender Y, Bickels J, Price WM et al (2000) Metastatic renal cell carcinoma of bone: indications and technique of surgical intervention. J Urol 164:1505–1508CrossRefPubMed
12.
Zurück zum Zitat Dürr HR, Maier M, Pfahler M et al (1999) Surgical treatment of osseous metastases in patinets with renal cell carcinoma. Clin Orthop Relat Res 367:283–290PubMed Dürr HR, Maier M, Pfahler M et al (1999) Surgical treatment of osseous metastases in patinets with renal cell carcinoma. Clin Orthop Relat Res 367:283–290PubMed
13.
Zurück zum Zitat Swanson DA, Orovan WL, Johnson DE et al (1981) Osseous metastasis secondary to renal cell carcinoma. Urology 18:556–561CrossRefPubMed Swanson DA, Orovan WL, Johnson DE et al (1981) Osseous metastasis secondary to renal cell carcinoma. Urology 18:556–561CrossRefPubMed
14.
Zurück zum Zitat Ficarra V, Righetti R, Martignoni G et al (2001) Prognostic value of renal cell carcinoma nuclear grading: multivariate analysis of 333 cases. Urol Int 67(2):130–4CrossRefPubMed Ficarra V, Righetti R, Martignoni G et al (2001) Prognostic value of renal cell carcinoma nuclear grading: multivariate analysis of 333 cases. Urol Int 67(2):130–4CrossRefPubMed
15.
Zurück zum Zitat Minervini A, Lilas L, Minervini R et al (2002) Prognostic value of nuclear grading in patients with intracapsular (pT1-pT2) renal cell carcinoma. Long-term analysis in 213 patients. Cancer 94(10):2590–2595CrossRefPubMed Minervini A, Lilas L, Minervini R et al (2002) Prognostic value of nuclear grading in patients with intracapsular (pT1-pT2) renal cell carcinoma. Long-term analysis in 213 patients. Cancer 94(10):2590–2595CrossRefPubMed
16.
Zurück zum Zitat Lang H, Lindner V, de Fromont M et al (2005) Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: assessment of 241 patients with > 15-year follow-up. Cancer 103(3):625–9CrossRefPubMed Lang H, Lindner V, de Fromont M et al (2005) Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: assessment of 241 patients with > 15-year follow-up. Cancer 103(3):625–9CrossRefPubMed
17.
Zurück zum Zitat Ficarra V, Martignoni G, Maffei N et al (2005) Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma. Cancer 103(1):68–75CrossRefPubMed Ficarra V, Martignoni G, Maffei N et al (2005) Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma. Cancer 103(1):68–75CrossRefPubMed
18.
Zurück zum Zitat Poel HG, Roukema JA, Horenblas S et al (1999) Metastasectomy in renal cell carcinoma: a multicenter retrospective analysis. Eur Urol 35:197–203CrossRefPubMed Poel HG, Roukema JA, Horenblas S et al (1999) Metastasectomy in renal cell carcinoma: a multicenter retrospective analysis. Eur Urol 35:197–203CrossRefPubMed
19.
Zurück zum Zitat Onishi T, Ohishi Y, Iizuka N et al (1995) Study on the pathological grade in the primary and distant metastatic lesions of renal cell carcinoma. Hinyokika Kiyo 41(12):959–63PubMed Onishi T, Ohishi Y, Iizuka N et al (1995) Study on the pathological grade in the primary and distant metastatic lesions of renal cell carcinoma. Hinyokika Kiyo 41(12):959–63PubMed
20.
Zurück zum Zitat Baloch KG, Grimer RJ, Carter SR et al (2000) Radical Surgery for the solitary bony metastasis from renal cell carcinoma. J Bone Joint Surg (Br) 82:62–67CrossRef Baloch KG, Grimer RJ, Carter SR et al (2000) Radical Surgery for the solitary bony metastasis from renal cell carcinoma. J Bone Joint Surg (Br) 82:62–67CrossRef
21.
Zurück zum Zitat Adiga GU, Dutcher JP, Larkin M (2004) Characterisation of bone metastases in patients with renal cell cancer. BJU Int 93:1237–1240CrossRefPubMed Adiga GU, Dutcher JP, Larkin M (2004) Characterisation of bone metastases in patients with renal cell cancer. BJU Int 93:1237–1240CrossRefPubMed
22.
Zurück zum Zitat Jung ST, Ghert MA, Harrelson JM et al (2003) Treatment of osseous metastases in patients with renal cell carcinoma. Clin Orthop Rel Res 409:223–231CrossRef Jung ST, Ghert MA, Harrelson JM et al (2003) Treatment of osseous metastases in patients with renal cell carcinoma. Clin Orthop Rel Res 409:223–231CrossRef
Metadaten
Titel
Prognostic Factors and Survival of Renal Clear Cell Carcinoma Patients with Bone Metastases
verfasst von
Attila Szendrői
Elek Dinya
Magdolna Kardos
A. Marcel Szász
Zsuzsanna Németh
Katalin Áts
János Kiss
Imre Antal
Imre Romics
Miklós Szendrői
Publikationsdatum
01.03.2010
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 1/2010
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-009-9184-7

Weitere Artikel der Ausgabe 1/2010

Pathology & Oncology Research 1/2010 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.